• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.

作者信息

Borghetti A, Ciccullo A, Paratore M, Rovedi F, Stella L, Marchetti A, Cattani P, Zileri Dal Verme L, Cauda R, Gasbarrini A, Di Giambenedetto S

机构信息

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Dipartimento di Sicurezza e Bioetica, Sezione di Malattie Infettive, Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

J Infect. 2021 Jan;82(1):159-198. doi: 10.1016/j.jinf.2020.05.044. Epub 2020 May 27.

DOI:10.1016/j.jinf.2020.05.044
PMID:32473233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7255159/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e7/7255159/db3a325a8316/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e7/7255159/db3a325a8316/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e7/7255159/db3a325a8316/gr1_lrg.jpg

相似文献

1
Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.用于评估新冠病毒检测呈阳性的预检概率的评分系统的推导与验证。
J Infect. 2021 Jan;82(1):159-198. doi: 10.1016/j.jinf.2020.05.044. Epub 2020 May 27.
2
[Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].[对疑似SARS-CoV-2感染进行微生物学检测的重复：基于临床概率的评分的效用]
Rev Esp Quimioter. 2020 Dec;33(6):410-414. doi: 10.37201/req/080.2020. Epub 2020 Sep 11.
3
COVID-19-related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis.与COVID-19相关的呼吸衰竭和淋巴细胞减少似乎与肺孢子菌病无关。
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1734-1736. doi: 10.1164/rccm.202007-2938LE.
4
Reply to Blaize : COVID-19-related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis.回复布莱兹：与 COVID-19 相关的呼吸衰竭和淋巴细胞减少似乎与肺孢子菌病无关。
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1736-1737. doi: 10.1164/rccm.202008-3174LE.
5
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
6
Prostaglandin D as a mediator of lymphopenia and a therapeutic target in COVID-19 disease.前列腺素 D 作为 COVID-19 疾病中淋巴细胞减少症的介质和治疗靶点。
Med Hypotheses. 2020 Oct;143:110122. doi: 10.1016/j.mehy.2020.110122. Epub 2020 Jul 21.
7
Lymphopenia in COVID-19: Therapeutic opportunities.新型冠状病毒肺炎中的淋巴细胞减少症：治疗机会。
Cell Biol Int. 2020 Sep;44(9):1792-1797. doi: 10.1002/cbin.11403. Epub 2020 Jun 3.
8
COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?新型冠状病毒肺炎与高效多发性硬化症疗法：一切照旧的时候到了吗？
Mult Scler. 2020 Sep;26(10):1267. doi: 10.1177/1352458520948211. Epub 2020 Aug 7.
9
Lymphopenia during the COVID-19 infection: What it shows and what can be learned.新冠病毒感染期间的淋巴细胞减少症：所呈现的情况及可从中了解到的信息。
Immunol Lett. 2020 Sep;225:31-32. doi: 10.1016/j.imlet.2020.06.013. Epub 2020 Jun 20.
10
Lymphopenia in critically ill COVID-19 patients: A predictor factor of severity and mortality.危重症COVID-19患者的淋巴细胞减少：严重程度和死亡率的预测因素。
Int J Lab Hematol. 2021 Feb;43(1):e38-e40. doi: 10.1111/ijlh.13351. Epub 2020 Sep 30.

引用本文的文献

1
Validation of a Nepali version of the questionnaire to assess preventive practices against the COVID-19 pandemic in the general population.一份用于评估普通人群针对新冠疫情预防措施的尼泊尔语问卷的验证。
BMC Public Health. 2024 Dec 18;24(1):3522. doi: 10.1186/s12889-024-21009-3.
2
Development and Validation of a Clinical Symptom-based Scoring System for Diagnostic Evaluation of COVID-19 Patients Presenting to Outpatient Department in a Pandemic Situation.大流行情况下就诊于门诊的COVID-19患者诊断评估的基于临床症状的评分系统的开发与验证
Cureus. 2021 Mar 3;13(3):e13681. doi: 10.7759/cureus.13681.
3
Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator).
新型冠状病毒肺炎（COVID-19）诊断临床决策支持：CORAL（COVID 风险计算器）的实施前后研究。
Clin Infect Dis. 2021 Dec 16;73(12):2248-2256. doi: 10.1093/cid/ciab111.